TGFB1 and keloid: The hypotheses is that this protocol will improve the distribution and organization of collagen in the scar tissue and diminish the expression of TGF-β, reducing the risk of recurrence of the keloid as well as improving the general appearance of the scar and the quality of life of the patient.